SG Americas Securities LLC Has $12.61 Million Stock Holdings in Sotera Health Company $SHC

SG Americas Securities LLC raised its position in shares of Sotera Health Company (NASDAQ:SHC) by 6,382.6% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 879,489 shares of the company’s stock after purchasing an additional 865,922 shares during the period. SG Americas Securities LLC owned approximately 0.31% of Sotera Health worth $12,612,000 at the end of the most recent reporting period.

A number of other large investors have also recently modified their holdings of SHC. IFP Advisors Inc lifted its holdings in shares of Sotera Health by 1,105.6% in the fourth quarter. IFP Advisors Inc now owns 1,495 shares of the company’s stock worth $26,000 after acquiring an additional 1,371 shares during the last quarter. Rothschild Investment LLC acquired a new position in Sotera Health during the 4th quarter worth approximately $27,000. True Wealth Design LLC lifted its stake in Sotera Health by 389.3% in the 4th quarter. True Wealth Design LLC now owns 1,830 shares of the company’s stock valued at $32,000 after purchasing an additional 1,456 shares during the last quarter. EverSource Wealth Advisors LLC lifted its stake in Sotera Health by 831.4% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 3,288 shares of the company’s stock valued at $37,000 after purchasing an additional 2,935 shares during the last quarter. Finally, Eurizon Capital SGR S.p.A. acquired a new stake in Sotera Health in the fourth quarter valued at approximately $40,000. Institutional investors and hedge funds own 91.03% of the company’s stock.

Analysts Set New Price Targets

Several brokerages have recently issued reports on SHC. Wall Street Zen downgraded shares of Sotera Health from a “strong-buy” rating to a “buy” rating in a report on Saturday, April 11th. Piper Sandler restated an “overweight” rating and set a $22.00 price objective (down from $24.00) on shares of Sotera Health in a research report on Wednesday, May 6th. The Goldman Sachs Group assumed coverage on Sotera Health in a report on Friday, June 5th. They issued a “buy” rating and a $20.00 target price for the company. UBS Group set a $19.00 price target on shares of Sotera Health in a research note on Wednesday. Finally, Weiss Ratings lowered shares of Sotera Health from a “hold (c)” rating to a “hold (c-)” rating in a report on Thursday, May 21st. Eight investment analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $20.25.

Sotera Health Stock Up 1.6%

Sotera Health stock opened at $17.38 on Friday. The firm has a market cap of $4.96 billion, a price-to-earnings ratio of 42.39 and a beta of 1.79. Sotera Health Company has a 52-week low of $10.93 and a 52-week high of $19.85. The company has a debt-to-equity ratio of 3.56, a quick ratio of 2.54 and a current ratio of 2.82. The firm has a 50 day moving average price of $15.79 and a two-hundred day moving average price of $16.32.

Sotera Health (NASDAQ:SHC) last posted its quarterly earnings data on Tuesday, May 5th. The company reported $0.18 EPS for the quarter, beating analysts’ consensus estimates of $0.17 by $0.01. Sotera Health had a net margin of 9.91% and a return on equity of 39.73%. The company had revenue of $280.05 million for the quarter, compared to analyst estimates of $270.78 million. During the same period in the prior year, the firm posted $0.14 EPS. The company’s quarterly revenue was up 10.0% on a year-over-year basis. Sotera Health has set its FY 2026 guidance at 0.930-1.010 EPS. Equities analysts predict that Sotera Health Company will post 0.88 EPS for the current year.

Insiders Place Their Bets

In other Sotera Health news, Director Gtcr Investment Xi Llc sold 12,735,301 shares of the stock in a transaction dated Wednesday, May 13th. The stock was sold at an average price of $15.17, for a total transaction of $193,194,516.17. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Insiders own 15.36% of the company’s stock.

Sotera Health Company Profile

Sotera Health Inc (NASDAQ: SHC) is a global provider of sterilization and laboratory testing services that support the medical device, pharmaceutical, life sciences and consumer product industries. Headquartered in Jacksonville, Florida, the company offers a suite of services designed to ensure products meet rigorous safety and regulatory requirements before reaching market.

Sotera Health operates through three primary service platforms. Its Sterigenics division delivers contract sterilization solutions, including ethylene oxide (EtO), gamma irradiation, electron beam and X-ray technologies.